Yellow vials on a manufacturing conveyer belt

A broad range of therapeutic areas

We produce medicines for patients across a broad range of major therapeutic areas, spanning both noncommunicable and infectious diseases.

Learn more

Cardiovascular

Infectious disease

Oncology

Immunology

CNS and anesthesia

Women's healthcare

Diabetes and metabolism

Gastroenterology

Respiratory and allergy

Dermatology

Our diverse and differentiated portfolio

Brands
We harness the power of numerous branded drugs, including 20 iconic brands as well as several global key brands to help patients manage their health.
Learn more
Generics
Our diverse range of generic medicines work in the same way and provide the same clinical benefits as their brand-name counterparts and help increase access for patients.
Learn more
Biosimilars
Biosimilars can offer important, and often more affordable, treatment alternatives for patients and their physicians to tackle serious health issues, such as cancer, diabetes and autoimmune diseases.
Learn more
Over-the-counter products
We deliver a variety of over-the-counter products, including dietary supplements, homeopathics and cosmetics that help to empower people across the globe to live healthier lives.
Learn more
Active pharmaceutical ingredients
With one of the world’s broadest portfolios of active pharmaceutical ingredients (API), we provide API to customers in more than 100 countries.
Learn more

Quality is our priority

We know that what we do directly impacts the health and well-being of patients. As a result, protecting patients and consumer health by ensuring the quality and safety of our products is at the heart of how we operate across our network. From product development to making or sourcing raw materials to producing finished dosage forms, every step of our development, manufacturing and monitoring processes is grounded in this commitment.

80+ billion
doses produced annually
1,400+
molecules
~60,000
customers
~30,000
SKUs

Our team of highly-trained scientists and technical professionals apply their extensive expertise to develop each product formulation and to identify the specific processes and technologies used to manufacture our products. All our applications are subject to a robust regulatory review before a product can be brought to market. We monitor the performance of our products after approval and identify and implement any changes necessary to ensure quality. Significant changes also are subject to review by regulatory agencies.

600+
medical and product safety professionals
1,000+
regulatory experts
2,500+
scientists
14,000+
sales and marketing professionals

Our extensive global network of manufacturing facilities in geographically diverse locations support our efforts to ensure reliable supply, and our facilities are routinely inspected by a number of health authorities globally. In 2019 alone, our facilities underwent more than 135 inspections around the world.



Our pipeline fuels the future

Our pipeline and research and development capabilities, which are focused on investments to continue moving the company up the value chain, include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a wide range of product types. We work to address unmet needs through science and innovation to bring important medicines to market, such as our pending once-monthly glatiramer acetate, a generic Symbicort®, a biosimilar to Avastin®, a biosimilar to Eylea® and biosimilar to Botox®, and serve patients at every stage of life.1 Some examples of our capabilities include:

  • Biosimilars and insulin analogs
  • Respiratory products
  • Complex sterile products
  • Topicals and transdermals
  • Complex oral solid dosage forms
  • Over-the-counter/parapharmaceuticals
  • High potency products
  • Traditional generics
  • Drug/device combinations

1COPAXONE is a registered trademark of Teva Pharmaceuticals Industries Ltd.
ADVAIR DISKUS is a registered trademark of Glaxo Group Limited.
SYMBICORT is a registered trademark of AstraZeneca AB.
BOTOX is a registered trademark of Allergan, Inc.
AVASTIN is a registered trademark of Genentech, Inc.
EYLEA is a registered trademark of Regeneron Pharmaceuticals, Inc.
PFIZER is a registered trademark of Pfizer Inc.

The information contained on this page is not for use in product detailing or promotion.


*Not all of the products listed have been approved for use in all countries. To learn which products have been approved for use in a particular country, please visit that country’s page for a full listing of available drug products.

Our story

Discover how our diverse and differentiated portfolio across a broad range of therapeutic areas contributes to our mission of empowering people to live healthier at every stage of life.

Understand our story